Stock Details
PFE is Pfizer Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 50.54$. Average daily volumn in 3 months 24.52M. Market cap 294.18B



Stock symbol : PFE. Exchange : NYSE. Currency : USD
Lastest price : 52.43$. Total volume : 33.03M. Market state PRE
Click reload if you want to check the lastest price on market!!!

Pfizer Inc. (PFE)
Last Price
52.43$
Change
1.49
Volume
33.03M

Previous Close50.94
Open51.69
Day Range51.08-52.88
Bid52.17 x 900
Ask52.40 x 2.2k
Volume33.03M
Average Volume24.52M
Market Cap294.18B
Beta0.71
52 Week Range38.93-61.71
Trailing P/E11.81
Foward P/E0.96
Dividend (Yield %)3.05%
Ex-Dividend Date2022-07-28



Financial Details


According to Pfizer Inc.'s financial reports the company's revenue in 2021 were 81.29B an increase( +97.56%) over the years 2020 revenue that were of 41.65B. In 2021 the company's total earnings were 21.98B while total earnings in 2020 were 9.16B( +133.33%).


Loading ...



Organization

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 trea... tment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Market Cap:
294.18B
Revenue:
81.29B
Total Assets:
181.48B
Total Cash:
1.94B


News about "Pfizer Inc."

pfizer-signs-new-32-billion-covid-vaccine-deal-with-us-government-image

Pfizer signs new $3.2 billion COVID vaccine deal with U.S. government

Source from : Reuters - 1 days ago

Pfizer Inc and partner BioNTech SE said on Wednesday they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine, which could be delivered as soon as later ...See details»


pfizer-inc-nysepfe-position-increased-by-south-shore-capital-advisors-image

Pfizer Inc. (NYSE:PFE) Position Increased by South Shore Capital Advisors

Source from : Defense World - 7 hours ago

South Shore Capital Advisors boosted its position in shares of Pfizer Inc. (NYSE:PFE โ€“ Get Rating) by 15.8% during the first quarter, according to the company in its most recent Form 13F filing with ...See details»


pfizer-asks-for-formal-us-approval-of-oral-covid-treatment-paxlovid-image

Pfizer asks for formal U.S. approval of oral COVID treatment Paxlovid

Source from : Reuters - 1 days ago

Pfizer Inc said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment Paxlovid, which is currently available under an emergency use authorization (EUA).See details»


pfizer-inc-nysepfe-shares-sold-by-spirit-of-america-management-corp-ny-image

Pfizer Inc. (NYSE:PFE) Shares Sold by Spirit of America Management Corp NY

Source from : Defense World - 7 hours ago

Spirit of America Management Corp NY cut its holdings in Pfizer Inc. (NYSE:PFE โ€“ Get Rating) by 42.4% during the first quarter, according to the company in its most recent Form 13F filing with the ...See details»


pfizer-seeks-fda-approval-for-covid-drug-in-high-risk-patients-image

Pfizer Seeks FDA Approval for Covid Drug in High-Risk Patients

Source from : Bloomberg on MSN.com - 1 days ago

Pfizer Inc. asked US regulators for full approval of Paxlovid, its Covid-19 drug thatโ€™s now used on an emergency basis, for people at high risk of developing severe disease.See details»


pfizer-seeks-fdas-full-approval-for-paxlovid-covid-19-pill-image

Pfizer Seeks FDAโ€™s Full Approval for Paxlovid Covid-19 Pill

Source from : Wall Street Journal - 1 days ago

Approval of Paxlovid, which has been available under an Food and Drug Administration authorization for use during the pandemic, would allow Pfizer to market and sell it commercially.See details»


pfizer-signs-new-32b-covid-vaccine-deal-with-us-government-image

Pfizer Signs New $3.2B Covid Vaccine Deal With US Government

Source from : Voice of America - 1 days ago

Pfizer Inc. and partner BioNTech said on Wednesday they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine.See details»


why-im-buying-pfizer-and-you-should-too-image

Why I'm Buying Pfizer And You Should Too

Source from : Entrepreneur - 1 days ago

Some investors have discounted Pfizer's (NYSE: PFE) future value since the peak of the pandemic is over, but demand for continued development of COVID vaccines for future variants remains strong.See details»


is-pfizer-stock-a-buy-now-image

Is Pfizer Stock a Buy Now?

Source from : Nasdaq - 1 days ago

Pfizer (NYSE: PFE) has been one of the safer stocks to hold. Its 31% gain during that time eclipses the S&P 500 and its 9% loss. However, investors still aren't paying a huge premium for the stock as ...See details»


us-government-calls-for-additional-doses-of-pfizerbiontech-covid-19-vaccine-image

US Government Calls For Additional Doses Of Pfizer/BioNTech COVID-19 Vaccine

Source from : YAHOO!Finance - 1 days ago

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have announced a new vaccine supply agreement with the U.S. government. Under the agreement, the U.S. government will receive 105 million doses ...See details»


Why Pfizer Stock Is Rising Today

Source from : Benzinga.com - 22 hours ago

Pfizerย Inc (NYSE: PFE) shares are trading higher Thursday after the company andย BioNTech SE (NASDAQ: BNTX) announced a new COVID-19 vaccine supply agreement with the U.S.ย government.See details»


is-pfizer-inc-nysepfe-popular-amongst-institutions-image

Is Pfizer Inc. (NYSE:PFE) Popular Amongst Institutions?

Source from : YAHOO!Finance - 4 days ago

Every investor in Pfizer Inc. (NYSE:PFE) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning shares ...See details»


Pfizer Submits NDA For PAXLOVID To FDA To Treat Severe Illness From COVID-19

Source from : Business Insider - 1 days ago

Pfizer Inc. (PFE) announced Thursday the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) ...See details»


pfizer-inc-nysepfe-shares-sold-by-pennsylvania-capital-management-inc-adv-image

Pfizer Inc. (NYSE:PFE) Shares Sold by Pennsylvania Capital Management Inc. ADV

Source from : ETF Daily News - 3 days ago

Pennsylvania Capital Management Inc. ADV lessened its stake in Pfizer Inc. (NYSE:PFE โ€“ Get Rating) by 67.8% during the 1st quarter, according to its most recent 13F filing with the Securities & ...See details»